{
    "eid": "2-s2.0-85137299825",
    "title": "Integration of In Silico Strategies for Drug Repositioning towards P38\u03b1 Mitogen-Activated Protein Kinase (MAPK) at the Allosteric Site",
    "cover-date": "2022-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "allosteric inhibitors",
        "computer-aided drug discovery",
        "drug repositioning",
        "in silico screening",
        "MD simulation",
        "molecular docking",
        "p38\u03b1 MAPK"
    ],
    "authors": [
        "Utid Suriya",
        "Panupong Mahalapbutr",
        "Thanyada Rungrotmongkol"
    ],
    "citedby-count": 1,
    "ref-count": 45,
    "ref-list": [
        "Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases",
        "A comprehensive structural overview of p38\u03b1 mitogen-activated protein kinase in complex with ATP-Site and non-ATP-site binders",
        "Targeting MAPK signaling in cancer: Mechanisms of drug resistance and sensitivity",
        "P38 MAP kinases: Key signalling molecules as therapeutic targets for inflammatory diseases",
        "The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis",
        "P38\u03b1 MAP kinase as a sensor of reactive oxygen species in tumorigenesis",
        "The stress kinase p38\u03b1 as a target for cancer therapy",
        "Pathological roles of MAPK signaling pathways in human diseases",
        "P38 MAPK inhibition: A promising therapeutic approach for COVID-19",
        "Diversity and versatility of p38 kinase signalling in health and disease",
        "An updated patent review of p38 MAP kinase inhibitors (2014\u20132019)",
        "Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site",
        "Therapeutic protein kinase inhibitors",
        "p38 pathway kinases as anti-inflammatory drug targets",
        "Safety and Efficacy of VX-702, a p38 MAP Kinase Inhibitor, in Rheumatoid arthritis. OP-0246 European League Against Rheumatism",
        "MAP kinase p38 inhibitors: Clinical results and an intimate look at their interactions with p38alpha protein",
        "Mitogen activated protein kinase inhibitors: Where are we now and where are we going?",
        "SWISS-MODEL: Homology modelling of protein structures and complexes",
        "PROCHECK: A program to check the stereochemical quality of protein structures",
        "Computation, PROPKA3: Consistent treatment of internal and surface residues in empirical pKa predictions",
        "ANTECHAMBER: An accessory software package for molecular mechanical calculations",
        "AutoDock VinaXB: Implementation of XBSF, new empirical halogen bond scoring function, into AutoDock Vina",
        "In silico elucidation of potent inhibitors and rational drug design against SARS-CoV-2 Papain-like protease",
        "In silico screening of DNA gyrase B potent flavonoids for the treatment of clostridium difficile infection from phytoHub database",
        "Computational screening of newly designed compounds against coxsackievirus A16 and enterovirus A71",
        "In silico screening of available drugs targeting non-small cell lung cancer targets: A drug repurposing approach",
        "Butoxy mansonone G inhibits STAT3 and akt signaling pathways in non-small cell lung cancers: Combined experimental and theoretical investigations",
        "Development and testing of a general amber force field",
        "Particle mesh ewald: An n\u22c5 log (N) method for ewald sums in large systems",
        "Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes",
        "Synchronization of trajectories in canonical molecular-dynamics simulations: Observation, explanation, and exploitation",
        "Molecular dynamics with coupling to an external bath",
        "Comparison of simple potential functions for simulating liquid water",
        "Solvated interaction energy (SIE) for scoring protein\u2212ligand binding affinities. 1. exploring the parameter space",
        "A new ONIOM implementation in Gaussian98. Part I. The calculation of energies, gradients, vibrational frequencies and electric field derivatives",
        "Chapter 3 hybrid methods: ONIOM(QM:MM) and QM/MM",
        "Electronic structure, binding energy, and solvation structure of the streptavidin\u2212biotin supramolecular complex: ONIOM and 3D-RISM study",
        "Decision making in structure-based drug discovery: Visual inspection of docking results",
        "Molecular dynamics simulation and free energy calculation studies of the binding mechanism of allosteric inhibitors with p38\u03b1 MAP kinase",
        "Nilotinib impairs skeletal myogenesis by increasing myoblast proliferation",
        "Molecular modeling of p38\u03b1 mitogen-activated protein kinase inhibitors through 3D-QSAR and molecular dynamics simulations",
        "Pharmagist: A webserver for ligand-based pharmacophore detection",
        "Comparative assessment of QM-based and MM-based models for prediction of protein\u2013ligand binding affinity trends"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60026046",
            "affilname": "Faculty of Medicine, Khon Kaen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026046",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "NSRF",
        "National Science, Research and Innovation Fund",
        "Science Achievement Scholarship",
        "Chulalongkorn University",
        "Khon Kaen University",
        "Thailand Research Fund",
        "SAST"
    ]
}